Skip to content
Back to Investors
HP

Hambro Perks

Venture Capital

London-headquartered international investment firm focussed on technology investing.


Recent investments

Series A
£10.0M

Experian participates in a £10m Series A round intended to fund credit protection tools for small businesses.

"Managing credit risk is central to lender activity but SME owners typically overlook it. This restricts their growth and jeopardises their survival. While the digitalisation of financial services was on course to deliver SMEs with efficient access to new capital providers, the pandemic highlighted the fragility of their supply chains. As they emerge, their ability to recover and protect capital, while boosting their appeal to the lending community will be crucial. Capital Reports will make an unprecedented and timely contribution to SMEs’ ability to survive, and grow, in the UK within the coming months, in South Africa in Q4 with more countries to follow."
— Ollie Maitlaind, CPO and Co Founder
Series A
£6.6M

The Series A round was led by Felix Capital with participation from existing investors to scale employee healthcare services.

"The pandemic has shown us that employers can’t just talk about supporting their employees’ health and wellbeing anymore, they have to take action. More and more leading businesses are turning to us to provide the support their people really need – not a one-size-fits all solution, but support that is trustworthy, personalised and delivered by experts. We’re still at the surface of what is possible for Peppy."
— Mridula Pore, Co-Founder and Co-CEO
Seed
£2.0M

The financing round was led by IQ Capital with participation from Hambro Perks and Ascension Ventures.

"This latest round of investment is a great recognition of our customers' success through our breakthrough AI and a product focused approach. With our existing investors reaffirming their support of the company and new investors with vast experience in the life sciences industry coming on board, we are on course to achieve our core mission of improving patient outcomes through a highly profitable and sustainable business model. In the past 12 months, the company has grown 15 times through the successful deployment of PIE in the biopharmaceutical industry, partnerships with healthcare data providers and significant contributions to peer review publications, which demonstrates that we are leading in this sector. This funding will accelerate this success by providing the resources to strengthen the team, explore new use cases, and expand into new markets."
— Vibhor Gupta, CEO
Series A
£2.9M

The financing round was led by Hambro Perks and Fair By Design.

"We’re delighted to have Hambro Perks and Ascension Ventures leading SteadyPay’s latest funding round. This raise will further strengthen our commitment to service the UK’s gig-economy with a powerful and ethical solution to income volatility. We’re thrilled with the results and customer feedback to date, and we look forward to driving scale in 2020."
— John Downie, Co-founder and CEO